ADELAIDE, AUS, Jun 4, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital […]

HONG KONG, May 24, 2021 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products […]

ADELAIDE, AUS, May 17, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ […]

TOKYO, Apr 1, 2021 – (JCN Newswire via SEAPRWire.com) – RIKEN and Fujitsu today announced the opening of the “RIKEN RQC-Fujitsu Collaboration Center” to promote joint research and development of foundational technologies to put superconducting quantum computers into practical use. More specifically, Riken and Fujitsu will develop hardware and software […]

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a research and prototype production contract with Japan’s Ministry of Defense for next-generation mine-countermeasure technology, a France-Japan joint research project being conducted based on agreement between defense authorities in the two countries. OZZ-5, […]

TOKYO, Mar 22, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that, as part of one strategic investment towards the realization of its medium-term business plan “EWAY2025”, it has conducted the groundbreaking ceremony for the construction of a new injection/research building “Eisai Medicine Innovation Technology Solutions” […]

TOKYO, Mar 17, 2021 – (JCN Newswire via SEAPRWire.com) – Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons […]